WallStreetZenWallStreetZen

NASDAQ: PVLA
Palvella Therapeutics Inc Stock Ownership - Who owns Palvella Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Palvella Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
George M. JenkinsDirector2025-04-092,500$20.13
$50.33kBuy
George M. JenkinsDirector2025-04-092,490$20.27
$50.47kBuy
George M. JenkinsDirector2024-12-184,000$12.93
$51.72kBuy

1 of 1

PVLA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PVLA insiders and whales buy or sell their stock.

PVLA Shareholders

What type of owners hold Palvella Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aquilo Capital Management LLC33.23%3,675,530$288.24MInsider
Wes Kaupinen14.53%1,607,228$126.04MInsider
Frazier Life Sciences Management LP6.53%722,400$56.65MInstitution
Suvretta Capital Management LLC6.46%714,463$56.03MInstitution
Bvf Inc6.30%696,555$54.62MInstitution
Woodline Partners LP4.03%445,615$34.95MInstitution
Blackrock Inc4.02%445,052$34.90MInstitution
Samsara Biocapital LLC3.07%339,743$26.64MInstitution
Millennium Management LLC2.85%314,989$24.70MInstitution
Adams Street Partners LLC2.70%298,986$23.45MInstitution

1 of 3

PVLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PVLA48.78%51.22%Net Buying
SPRY44.58%55.42%Net SellingNet Selling
BCAX70.82%29.18%Net SellingNet Selling
GHRS70.22%0.00%
KURA90.43%9.57%Net SellingNet Buying
View Top Biotech Stocks

Palvella Therapeutics Stock Ownership FAQ

Who owns Palvella Therapeutics?

Palvella Therapeutics (NASDAQ: PVLA) is owned by 53.43% institutional shareholders, 56.10% Palvella Therapeutics insiders, and 0.00% retail investors. Aquilo Capital Management LLC is the largest individual Palvella Therapeutics shareholder, owning 3.68M shares representing 33.23% of the company. Aquilo Capital Management LLC's Palvella Therapeutics shares are currently valued at $293.45M.

If you're new to stock investing, here's how to buy Palvella Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.